Experimental design and analysis and their reporting: New guidance for publication in BJP

British Journal of Pharmacology

Volumn 172, Issue 14, 2015, Pages 3461-3471

  Curtis, Michael J ^a   Bond, Richard A ^a   Spina, Domenico ^a   Ahluwalia, Amrita ^a   Alexander, Stephen P A ^a   Giembycz, Mark A ^a   Gilchrist, Annette ^a   Hoyer, Daniel ^a   Insel, Paul A ^a   Izzo, Angelo A ^a   Lawrence, Andrew J ^a   Macewan, David J ^a   Moon, Lawrence D F ^a   Wonnacott, Sue ^a   Weston, Arthur H ^a   McGrath, John C ^a  

^a British Pharmacological Society   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DATA ANALYSIS; EXPERIMENTAL DESIGN; INFORMATION PROCESSING; MEDICAL LITERATURE; OBSERVER BIAS; PLACEBO EFFECT; PRIORITY JOURNAL; PUBLICATION; RANDOMIZATION; RESEARCH ETHICS; REVIEW; SAMPLE SIZE; STATISTICAL ANALYSIS; STUDENT T TEST; ANIMAL; HUMAN; METHODOLOGY; PEER REVIEW; PUBLISHING; RESEARCH; STANDARDS;

ANIMALS; EDITORIAL POLICIES; HUMANS; PEER REVIEW, RESEARCH; PERIODICALS AS TOPIC; RESEARCH DESIGN; RESEARCH REPORT;

EID: 84929204828     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12856     Document Type: Review

References (38)

1. Altman DG, Gore SM, Gardner MJ, Pocock SJ, (1983). Statistical guidelines for contributors to medical journals. Brit Med J 286: 1489-1493.
2. Baker D, Lidster K, Sottomayor A, Amor S, (2014). Two years later: journals are not yet enforcing the ARRIVE Guidelines on reporting standards for pre-clinical animal studies. PLoS Biol 12: e1001756.
3. Ball P, (2004). The memory of water. The life and work of Jacques Benveniste taught us valuable lessons about how to deal with fringe science. Available at: http://www.nature.com/news/2004/041004/full/news041004-19.html (accessed 15/6/2014).
4. Basel Declaration Society (2011). The Basel Declaration. Available at: http://www.basel-declaration.org (accessed 10/2/2015).
5. Best practice in statistical reporting. British Journal of Pharmacology Virtual Issue: Best Practice in Statistical Reporting http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1476-5381/homepage/statistical-reporting.htm
6. Button KS, Ioannidis JPA, Mokrysz C, Nosek BA, Flint J, Robinson ESJ, et al. (2013). Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 14: 365-376.
7. CMS Collaboration (2012). Observation of a new boson at a mass of 125 GeV with the CMS experiment at the LHC. Phys Lett B 716: 30-61.
8. Colquhoun D, (2014). An investigation of the false discovery rate and the misinterpretation of p-values. Royal Society Open Science. 20141:140216. DOI: 10.1098/rsos.140216.
9. Curtis MJ, Hancox JC, Farkas A, Wainwright CL, Stables CL, Saint DA, et al. (2013). The Lambeth Conventions (II): guidelines for the study of animal and human ventricular and supraventricular arrhythmias. Pharmaco Ther 139: 213-248
10. Davenas E, Beauvais F, Amara J, Oberbaum M, Robinzon B, Miadonnai A, et al. (1988). Human basophil degranulation triggered by very dilute antiserum against IgE. Nature 333: 816-818.
11. Gensburger D, Roux JP, Arlot M, Sornay-Rendu E, Ravaud P, Chapurlat R, (2012). Influence of blinding sequence of radiographs on the reproducibility and sensitivity to change of joint space width measurement in knee osteoarthritis. Arthritis Care Res 62: 1699-1705.
12. Head ML, Holman L, Lanfear R, Kahn AT, Jennions MD, (2015). The extent and consequences of P-Hacking in science. PLoS Biol 13: e1002106.
13. Halsey LG, Curran-Everett D, Vowler SL, Drummond GB, (2015). The fickle P value generates irreproducible results. Nat Methods 12: 179-185
14. Hrõbjartsson A, Thomsen ASS, Emanuelsson F, Tendal B, Hilden J, Boutron I, et al. (2012). Surgeon observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors. BMJ 2012: e1119.
15. Ioannidis JPA, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, et al. (2014). Increasing value and reducing waste in research design, conduct, and analysis. Lancet 383: 166-175.
16. John RM, Tedrow UB, Koplan BA, Albert CM, Epstein LM, Sweeney MO, et al. (2012). Ventricular arrhythmias and sudden cardiac death. Lancet 380: 1520-1529.
17. Kenakin T, Bylund DB, Toews ML, Mullane K, Winquist RJ, Williams M, (2014). Replicated, replicable and relevant-target engagement and pharmacological experimentation in the 21st century. Biochem Pharmacol 87: 64-77.
18. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG, (2010). Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 8: e1000412.
19. Kitchen I, (1987). Statistics and pharmacology: the bloody obvious test. Trends Pharmacol Sci 8: 252-253.
20. Lazic SE, (2010). The problem of pseudoreplication in neuroscientific studies: is it affecting your analysis? BMC Neurosci 11: 5.
21. Lehr R, (1992). Sixteen S-squared over D-squared: a relation for crude sample size estimates. Statistic in Medicine 11: 1099-1102. http://www.gpower.hhu.de (accessed 04/03/15).
22. McGrath JC, Curtis MJ, (2015). BJP is changing its requirements for scientific papers to increase transparency. Br J Pharmacol 172: 2671-2674.
23. McGrath JC, Lilley E, (2015). Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol 172: 3189-3193.
24. McGrath JC, McLachlan EM, Zeller R, (2015a). Transparency in Research involving Animals: The Basel Declaration and new principles for reporting research in BJP manuscripts. Br J Pharmacol 172: 2427-2432.
25. McGrath JC, Pawson AJ, Sharman JL, Alexander SPH, (2015b). BJP is linking its articles to the IUPHAR/BPS Guide to PHARMACOLOGY. Br J Pharmacol 172: 2929-2932.
26. Macleod MR, Michie S, Roberts I, Ulrich Dirnagl U, Chalmers I, Ioannidis JPA, et al. (2014). Design animal studies better. Nature 510: 35.
27. Mainland D, Herrera L, Sutcliffe MI, (1956). Statistical tables for use with binomial samples-contingeny tests, confidence limits and sample size estimates. Department of Medical Statistics, New York University College of Medicine.
28. Mainland D, (1957). Safety in numbers. Circulation 16: 784-790.
29. Marino MJ, (2014). The use and misuse of statistical methodologies in pharmacology research. Biochem Pharmacol 87: 78-92.
30. Motulsky H, (2015). Common misconceptions about data analysis and statistics and how to avoid them. Br J Pharmacol 172: 2126-2132.
31. Mullard A, (2011). Reliability of 'new drug target' claims called into question. Nat Rev Drug Discov 10: 643-644.
32. Nature Editorial (2014). Journals unite for reproducibility Nature 515: 7.
33. Parker RM, Browne WJ, (2014). The Place of Experimental Design and Statistics in the 3Rs. ILAR J 55: 477-485.
34. Research Councils UK (2015). Updated RCUK guidance for funding applications involving animal research. Available at: http://www.rcuk.ac.uk/media/announcements/150415/ (accessed 24/04/2015).
35. Scott S, Ktranz JE, Cole J, Lincecum JM, Thompson K, Kelly N, et al. (2008). Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph Lateral Scler 9: 4-15.
36. Tsilidis KK, Panagiotou OA, Sena ES, Aretouli E, Evangelou E, Howells DW, et al. (2013). Evaluation of excess significance bias in animal studies of neurological disease. PLoS Biol 11: e1001609.
37. U.S. National Institutes of Health (2014). Principles and Guidelines for Reporting Preclinical Research: Available at: http://www.nih.gov/about/reporting-preclinical-research.htm (accessed 10/2/2015).
38. U.S. National Institutes of Health (2015). http://www.nigms.nih.gov/training/pages/clearinghouse-for-training-modules-to-enhance-data-reproducibility.aspx: (accessed 4/4/2015).